Viral Immunologist Dr. Byram Bridle Speaks Out (Nov 26, 2022)

"Dr. Bridle is a viral immunologist who is passionate about improving life through two avenues of research. One arm of his research program is dedicated to designing and optimising novel biotherapies for the treatment of cancers. The second arm focuses on studying host responses to viruses and other inflammatory stimuli.
Documents and websites referred to during Byram’s webinar
Byram’s evidence filed in the Kids’ Case:
Associate Professor Bridle has produced three reports in support of the Kids’ Case:
The first report covers – experience from the Canadian vaccine programme, and the disproportionate number of vaccinated being overrepresented in hospitals. This report includes discussion of the biodistribution reports Pfizer provided to the Japanese authorities.
You can read that here (Affidavit – 25 Jan).
https://www.thehoodnz.com/storage/app/media/Kids%20Case/Bridle_Affadavit2.pdf
Second report covers - commentary on the English version of Pfizer’s biodistribution report following release of FDA documents under an FOI ruling – that English version of the biodistribution report confirmed AP Bridle’s initial comments in May of 2022 (re Pfizer’s Japanese version) – but the information was even more concerning as it now distinguished the biodistribution of the products in male and females. You can read that report HERE
https://www.thehoodnz.com/storage/app/media/Kids%20Case/BridleFurther2.pdf
Third report is in direct response to criticisms levelled at Dr Bridle by the Crown. This report discusses the different nature of vaccines. You can read that report HERE
https://www.thehoodnz.com/storage/app/media/Kids%20Case/BridleReply2.pdf
Pfizer: 1290 events of special interest
The Pfizer report setting out 1290 events of special interest is 5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021 see APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST(PDF page 3)
Or URL link to report: https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf
Biodistribution Reports
Japanese version released May 2021: https://www.thehoodnz.com/storage/app/media/Kids%20Case/BridleFurther2.pdf
(PDF page 35)
Version in English released March 2022: https://www.thehoodnz.com/storage/app/media/Kids%20Case/BridleFurther2.pdf
(PDF page 58)
Analysis of our CARM data:
Ms Mitchell is a statistician. She provided expert opinion in respect to adverse events following the COVID-19 products in both New Zealand and Australia.
Specifically, she outlines whether Medsafe had access to information which showed significant levels of adverse reactions to the Pfizer Comirnaty paediatric vaccine and on the basis of that information, whether Medsafe should have made the decision that it did to grant provisional consent for the vaccination of children between the 5 and 11 years old. (...)“
Source:
https://odysee.com/@voicesforfreedom:6/FREEDOM-TV-SPECIAL-GUEST-DR-BYRAM-BRIDLE